US EditionPublished • loading... • Updated
Cost-effectiveness Analysis of “Test and Treat” Strategy compared to “Test, Triage and Treat” Strategy for screening pre- cervical cancer lesions among women Living with HIV at Uganda Cancer institute
Summary by researchsquare.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Cost-effectiveness Analysis of “Test and Treat” Strategy compared to “Test, Triage and Treat” Strategy for screening pre- cervical cancer lesions among women Living with HIV at Uganda Cancer institute
Background: Cervical cancer is the fourth most common cancer in women globally, with around 660,000 new cases and 350,000 deaths and Uganda is among the top ten countries with the highest incidence of cervical cancer. In 2021, Uganda adopted "Test, Triage and Treat" (TTT) inco...
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
